ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
August 14, 2019 09:02 ET
|
ReNetx Bio
NEW HAVEN, Conn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- ReNetX Bio, Inc., a leading biotechnology company committed to reversing disease and damage for patients suffering from central nervous system...
Rise in Medical Cannabis Research Spurs Demand For Precise Measurement Tools
June 05, 2019 09:00 ET
|
Gofire, Inc.
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Healthcare technology firm Gofire™, an innovator of hardware and software solutions that aid in dose delivery, health tracking, and medication management,...
Ossa Fisher Named Istation’s President
January 08, 2019 10:28 ET
|
Istation Inc.
Dallas, TX, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Ossa Fisher is the new president of Istation, a Dallas-based education technology company providing computer-adaptive assessments and instruction in...
Farooq Kathwari Honored With Yale Chief Executive Leadership Institute's Lifetime of Leadership Award
June 21, 2018 14:01 ET
|
Ethan Allen
DANBURY, Conn., June 21, 2018 (GLOBE NEWSWIRE) -- Ethan Allen chairman, president and CEO Farooq Kathwari accepted the Yale Chief Executive Leadership Institute's (CELI) Lifetime of Leadership Award...
Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board
February 12, 2018 10:00 ET
|
ReNetX Bio
NEW HAVEN, Conn., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sven Jacobson will be the first to admit that developing a new therapeutic for spinal cord injury is a challenging road. But the latest member of...
Predictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory Board
January 04, 2018 09:00 ET
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Utah, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Dr. Hugh S. Taylor, M.D., joined the Predictive Technology Group’s Scientific...
A New Program at Yale Takes Aim at Opioid and other Substance Abuse using Entrepreneurship
November 15, 2017 10:55 ET
|
Innovation to Impact
NEW HAVEN, Conn., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Yale University has announced a national program called Innovation to Impact to speed to market innovations that can directly fight substance...
ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial
November 07, 2017 13:00 ET
|
ReNetx Bio
NEW HAVEN, Conn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- The Wings for Life foundation has made a significant commitment to ReNetX Bio, a New-Haven, Conn. based biotech startup that is advancing a...
SENS Research Foundation Announces New Research Program on Developing Monoclonal Antibodies Against Glucosepane With David Spiegel Lab
September 18, 2017 11:00 ET
|
SENS Research Foundation
MOUNTAIN VIEW, Calif., Sept. 18, 2017 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF) has launched a new research program focused on developing monoclonal antibodies against glucosepane. David A....
Family Office Exchange Launches 2017 Webinar Series with “Investors Chasing Yale and the Future of Alpha”
January 26, 2017 11:00 ET
|
Family Office Exchange LLC
CHICAGO, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Family Office Exchange (FOX), the leading peer-to-peer network for ultra-wealthy families, will begin its 2017 series of complimentary public webinars with...